TY - JOUR
T1 - Function, Therapeutic Potential, and Inhibition of Hsp70 Chaperones
AU - Ambrose, Andrew J.
AU - Chapman, Eli
N1 - Funding Information:
This work was supported by funding from the National Institutes of Health (NIH) T32 Training Grant No. GM008804 to A.J.A. and R01ES031463 from the National Institute of Environmental Health Sciences to E.C.
Publisher Copyright:
© 2021 American Chemical Society.
PY - 2021/6/10
Y1 - 2021/6/10
N2 - Hsp70s are among the most highly conserved proteins in all of biology. Through an iterative binding and release of exposed hydrophobic residues on client proteins, Hsp70s can prevent aggregation and promote folding to the native state of their client proteins. The human proteome contains eight canonical Hsp70s. Because Hsp70s are relatively promiscuous they play a role in folding a large proportion of the proteome. Hsp70s are implicated in disease through their ability to regulate protein homeostasis. In recent years, researchers have attempted to develop selective inhibitors of Hsp70 isoforms to better understand the role of individual isoforms in biology and as potential therapeutics. Selective inhibitors have come from rational design, forced localization, and serendipity, but the development of completely selective inhibitors remains elusive. In the present review, we discuss the Hsp70 structure and function, the known Hsp70 client proteins, the role of Hsp70s in disease, and current efforts to discover Hsp70 modulators.
AB - Hsp70s are among the most highly conserved proteins in all of biology. Through an iterative binding and release of exposed hydrophobic residues on client proteins, Hsp70s can prevent aggregation and promote folding to the native state of their client proteins. The human proteome contains eight canonical Hsp70s. Because Hsp70s are relatively promiscuous they play a role in folding a large proportion of the proteome. Hsp70s are implicated in disease through their ability to regulate protein homeostasis. In recent years, researchers have attempted to develop selective inhibitors of Hsp70 isoforms to better understand the role of individual isoforms in biology and as potential therapeutics. Selective inhibitors have come from rational design, forced localization, and serendipity, but the development of completely selective inhibitors remains elusive. In the present review, we discuss the Hsp70 structure and function, the known Hsp70 client proteins, the role of Hsp70s in disease, and current efforts to discover Hsp70 modulators.
UR - http://www.scopus.com/inward/record.url?scp=85108021247&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85108021247&partnerID=8YFLogxK
U2 - 10.1021/acs.jmedchem.0c02091
DO - 10.1021/acs.jmedchem.0c02091
M3 - Review article
C2 - 34009983
AN - SCOPUS:85108021247
SN - 0022-2623
VL - 64
SP - 7060
EP - 7082
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 11
ER -